Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Pro members get actionable news alerts up to 30 minutes before other traders — Get our lowest prices
Pro members get actionable news alerts up to 30 minutes before other traders — Get our lowest prices
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Protara Therapeutics Inc has a consensus price target of $23.33 based on the ratings of 3 analysts. The high is $25 issued by Oppenheimer on August 12, 2024. The low is $22 issued by Guggenheim on July 10, 2023. The 3 most-recent analyst ratings were released by Oppenheimer, HC Wainwright & Co., and HC Wainwright & Co. on August 12, 2024, August 8, 2024, and May 6, 2024, respectively. With an average price target of $23.67 between Oppenheimer, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 1145.61% upside for Protara Therapeutics Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Protara Therapeutics (NASDAQ:TARA) was reported by Oppenheimer on August 12, 2024. The analyst firm set a price target for $25.00 expecting TARA to rise to within 12 months (a possible 1181.72% upside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for Protara Therapeutics (NASDAQ:TARA) was provided by Oppenheimer, and Protara Therapeutics maintained their outperform rating.
There is no last upgrade for Protara Therapeutics
There is no last downgrade for Protara Therapeutics.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Protara Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Protara Therapeutics was filed on August 12, 2024 so you should expect the next rating to be made available sometime around August 12, 2025.
While ratings are subjective and will change, the latest Protara Therapeutics (TARA) rating was a maintained with a price target of $30.00 to $25.00. The current price Protara Therapeutics (TARA) is trading at is $1.95, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.